Streetbeat News

ETAO

Etao International Co Ltd.

Open

2.80

Mkt cap

9.8M

Volume

154K

High

3.02

P/E Ratio

-0.01

52-wk high

22.00

Low

1.71

Div yield

N/A

52-wk low

1.71

In Wednesday's after-market session, health care stocks saw significant movements with CytomX Therapeutics, ZimVie, and Aesthetic Medical Intl leading the gains, while Etao International, Enhabit, and Myomo were among the top losers. Most movements were influenced by the release of Q1 earnings.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 8:31 pm

In Wednesday's pre-market session, health care stocks saw significant movements. INVO Bioscience led the gainers with a 93.4% increase following their Q4 earnings release. Other notable gainers include Clene, Galera Therapeutics, Vanda Pharma, Chromocell Therapeutics, and BIMI Intl Medical. On the losing side, Sage Therapeutics saw the largest drop of 19.4%, followed by declines in Ontrak, China SXT Pharmaceuticals, Dynatronics, Etao International Co, and Precision BioSciences.

Portfolio Pulse from Benzinga Insights

April 17, 2024 | 12:08 pm

In Wednesday's intraday session, several healthcare stocks experienced significant movements. Adial Pharmaceuticals led the gainers with a 61.6% increase, while Acorda Therapeutics headed the losers with a 20.4% decrease. Other notable movers included Jaguar Health, Orgenesis, BioSig Technologies, and Telomir Pharmaceuticals on the gainers' side, and Kineta, DocGo, Biophytis, Yield10 Bioscience, and Eyenovia among the losers.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 4:31 pm

In Tuesday's pre-market session, several healthcare stocks showed significant movement. Acrivon Therapeutics, Biophytis, MyMD Pharmaceuticals, Addex Therapeutics, Brainstorm Cell, and Inspire Veterinary were among the gainers, with Acrivon Therapeutics leading with a 72.3% increase. On the downside, Vincerx Pharma, BioSig Technologies, Neogen, Tilray Brands, YS Biopharma Co, and Etao International Co experienced declines, with Vincerx Pharma dropping by 64.7%. Notably, Inspire Veterinary, Neogen, and Tilray Brands released their earnings reports.

Portfolio Pulse from Benzinga Insights

April 09, 2024 | 12:09 pm

In Monday's intraday session, several healthcare stocks experienced significant movements. Etao International Co led the gainers with a 96.6% increase, while Universe Pharmaceuticals topped the losers, declining by 18.2%. Other notable movers included Longeveron, Adlai Nortye, and Onconetix on the gainers' side, and Agenus, MiNK Therapeutics, and CNS Pharma among the losers.

Portfolio Pulse from Benzinga Insights

April 08, 2024 | 4:31 pm

Etao International's shares have resumed trading. This development could indicate a resolution to any issues that previously halted trading, potentially impacting investor confidence and stock performance.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 4:07 pm

Shares of Etao International were halted due to a circuit breaker triggered by a rapid upside movement, with the stock now showing a significant increase of 178.9%.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 4:04 pm

Etao International's shares have resumed trading. This development could indicate a resolution to any issues that previously halted its trading activities, potentially signaling a positive outlook for the company.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 3:54 pm

Etao International's shares were halted due to a circuit breaker triggered by a rapid increase, with the stock now up 93%.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 3:49 pm

In Friday's after-market session, several healthcare stocks showed notable movements. Longeveron (LGVN) led the gainers with a 48.6% increase, while Elicio Therapeutics (ELTX) experienced the largest decline among the losers, dropping 10.3%. Other notable movers included Adial Pharmaceuticals (ADIL), Etao International Co (ETAO), and Inovio Pharmaceuticals (INO) with significant gains, and SINTX Techs (SINT), Cerus (CERS), and MediciNova (MNOV) among the losers.

Portfolio Pulse from Benzinga Insights

April 05, 2024 | 8:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.